Speaker illustration

Doctor Arief Rahadian

Institute of Health Biosciences- The University of Tokushima Graduate School, Tokushima (Japan)

Arief Rahadian MD, graduated from Diponegoro University, Indonesia and continue his study as PhD at Tokushima University, Japan, in the Cardiovascular Department since 2017.

Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice

Event: ESC Congress 2019

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Lipids and metabolism


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb